AIHCC
Index Performance
+3.42%
AIHCC
+1.44%
IBB
Overview
Description
The Intelligent Healthcare Conviction strategy (AIHC) uses OpenAI's ChatGPT, Google's Bard, and Inflection AI's Claude to build an equal weighted portfolio of the committee's highest conviction US-listed stocks in the healthcare sector. The strategy aims to create superior quality-focused returns compared to the MSCI US Investable Market Health Care 25/50 Index.
- TickerAIHCC
- Inception Date10/16/2023
- WeightingEqual
- # of holdings30
What's inside?
Holdings
All holdings as of May 17, 2024
CSV download
| Shockwave Medical, Inc. (SWAV) | 3.89% | $12.39B | 35.85% | 87.11% | 15.58 |
| AstraZeneca PLC (AZN) | 3.81% | $237.49B | 11.68% | 75.21% | 4.95 |
| Amgen, Inc. (AMGN) | 3.76% | $167.62B | 22.19% | 56.73% | 7.04 |
| ResMed, Inc. (RMD) | 3.72% | $32.11B | 7.17% | 56.94% | 6.57 |
| Insulet Corp. (PODD) | 3.65% | $13.12B | 23.35% | 70.16% | 7.46 |
| Boston Scientific Corp. (BSX) | 3.64% | $109.75B | 13.78% | 61.83% | 7.50 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 3.53% | $114.89B | 14.21% | 87.25% | 9.80 |
| Merck & Co., Inc. (MRK) | 3.51% | $332.28B | 8.38% | 75.11% | 5.96 |
| UnitedHealth Group, Inc. (UNH) | 3.47% | $482.86B | 8.56% | N/A | 1.42 |
| Elevance Health, Inc. (ELV) | 3.46% | $127.30B | 0.96% | N/A | 0.86 |
| Danaher Corp. (DHR) | 3.45% | $196.87B | -19.13% | 60.16% | 7.59 |
| Biogen, Inc. (BIIB) | 3.40% | $33.57B | -5.62% | 68.65% | 4.02 |
| Medtronic Plc (MDT) | 3.35% | $114.09B | 4.68% | 60.33% | 4.09 |
| IDEXX Laboratories, Inc. (IDXX) | 3.32% | $44.88B | 7.10% | 61.60% | 12.35 |
| Pfizer Inc. (PFE) | 3.31% | $162.29B | -18.61% | 70.56% | 3.92 |
| Eli Lilly & Co. (LLY) | 3.30% | $731.81B | 25.98% | 80.91% | 20.23 |
| Thermo Fisher Scientific, Inc. (TMO) | 3.30% | $227.24B | -3.41% | 40.76% | 5.92 |
| DexCom, Inc. (DXCM) | 3.25% | $52.24B | 24.21% | 61.01% | 15.12 |
| Intuitive Surgical, Inc. (ISRG) | 3.25% | $141.46B | 11.46% | 65.87% | 19.01 |
| Becton, Dickinson & Co. (BDX) | 3.24% | $68.29B | 4.65% | 45.67% | 4.39 |
| Hologic, Inc. (HOLX) | 3.19% | $17.51B | -0.85% | 55.27% | 4.77 |
| Johnson & Johnson (JNJ) | 3.16% | $372.17B | -13.55% | 68.78% | 4.37 |
| Edwards Lifesciences Corp. (EW) | 3.12% | $53.72B | 9.50% | 75.72% | 9.24 |
| Zimmer Biomet Holdings, Inc. (ZBH) | 3.11% | $24.72B | 3.18% | 61.90% | 4.38 |
| Stryker Corp. (SYK) | 3.08% | $127.50B | 9.73% | 60.92% | 7.10 |
| AbbVie, Inc. (ABBV) | 3.05% | $293.88B | 0.70% | 66.84% | 6.96 |
| Gilead Sciences, Inc. (GILD) | 3.00% | $84.37B | 5.66% | 76.79% | 4.03 |
| Penumbra, Inc. (PEN) | 2.96% | $7.89B | 15.43% | 64.11% | 7.95 |
| GE Healthcare Technologies, Inc. (GEHC) | 2.96% | $37.37B | -1.21% | 41.23% | 2.51 |
| Bristol Myers Squibb Co. (BMY) | 2.76% | $89.25B | 4.66% | 55.54% | 3.46 |
Market data by FactSet